Research Peptide
KLOW 80MG
$110.00
● In Stock
A research blend combining GHK-Cu, KPV, BPC-157, and TB-500 in a single lyophilized vial for consolidated repair-pathway studies.
Purity
≥99.0% per component
Mol. Weight
Multi-component blend
Amino Acid Sequence
GHK-Cu / KPV / BPC-157 / TB-500
Storage
Store lyophilized peptide at -20°C in a sealed vial away from light and moisture. After reconstitution with bacteriostatic water, keep refrigerated at 2–8°C and use within 30 days. Do not freeze reconstituted solution.
Certificate of Analysis
View third-party lab report · LOT #NP-KLOW-26
KLOW is a co-lyophilized four-peptide research blend combining GHK-Cu, KPV, BPC-157, and TB-500 in a single 80 mg vial. Each component targets a distinct arm of the tissue-repair cascade. Reported research benefits: accelerated skin and soft-tissue healing through combined collagen synthesis (GHK-Cu) and cell migration (TB-500); reduced inflammation and cytokine release via KPV and BPC-157 activity in dermal and gut models; support for follicular regeneration and reduction of scarring; improved outcomes in colitis and IBD models through convergent anti-inflammatory pathways; enhanced angiogenesis into wound beds; and standardized molar ratios that reduce reconstitution error compared with four separate vials.
Related Products
Retatrutide 30MG
Triple agonist — high-dose vial for extended studies.
Retatrutide 50MG
Triple agonist — bulk presentation for long-term protocols.
Tirzepatide 10MG
First-in-class dual GIP / GLP-1 receptor agonist.